SCISPARC LTD (SPRC:NASDAQ)

$5.29 0.16 (3.1189%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 83

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SCISPARC LTD (SPRC:NASDAQ) News Sources

NeuroThera Labs Achieves Significant Enrollment Momentum in SCI210 Autism Clinical Trial

31-08-2026

yahoo.com

SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation for Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies

02-09-2026

yahoo.com

SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company

29-07-2026

yahoo.com

SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics

31-07-2026

yahoo.com

SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome

05-08-2026

yahoo.com

SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination

12-08-2026

yahoo.com

SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 Million Financing with SciSparc’s Stake Valued at Approximately C$30 Million

18-08-2026

yahoo.com

SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

24-08-2026

yahoo.com

SciSparc Advances Agentic AI Strategy with Addition of Internationally Recognized AI Expert Prof. Carmel Domshlak to Scientific Advisory Board

26-08-2026

yahoo.com

SciSparc: Subsidiary NeuroThera Labs Achieves Significant Enrollment Momentum in SCI‑210 Autism Clinical Trial

31-08-2026

yahoo.com

SCISPARC LTD (SPRC:NASDAQ) Sentiment Trend

0 25 50 75 100 82 85 82 87 85 83 79 80 79 85 31-08-2026 02-09-2026 29-07-2026 31-07-2026 05-08-2026 12-08-2026 18-08-2026 24-08-2026 26-08-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

SCISPARC LTD (SPRC:NASDAQ) FAQs

toggle

What is the current price of SCISPARC LTD (SPRC:NASDAQ)?

The current price of SCISPARC LTD (SPRC:NASDAQ) is $5.29.


toggle

SCISPARC LTD (SPRC:NASDAQ) absolute price change since previous trading day?

The absolute price change of SCISPARC LTD (SPRC:NASDAQ) since the previous trading day is $0.16.


toggle

SCISPARC LTD (SPRC:NASDAQ) percentage price change since previous trading day?

The percentage price change of SCISPARC LTD (SPRC:NASDAQ) since the previous trading day is 3.1189%.


toggle

What is the most recent average sentiment score for SCISPARC LTD (SPRC:NASDAQ)?

The most recent average sentiment score for SCISPARC LTD (SPRC:NASDAQ) is 83 out of 100.


toggle

What is the most recent average sentiment for SCISPARC LTD (SPRC:NASDAQ)?

The most recent sentiment for SCISPARC LTD (SPRC:NASDAQ) is .


SEC-8K** Filing Available For SCISPARC LTD (SPRC:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.